Vycor Medical (VYCO) Profit After Tax Growth (3y) (2013 - 2026)
Powered by 
Analysis
Vycor Medical (VYCO) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 21.98% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 22.89% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 20.02% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 49.66% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -7.65% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 29.05% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 15.46% |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -32.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.29% |
| Mar 31, 2026 | 38.50% |
| Dec 31, 2025 | 18.68% |
| Sep 30, 2025 | 26.90% |
| Jun 30, 2025 | 31.23% |
| Mar 31, 2025 | 19.73% |
| Dec 31, 2024 | 66.98% |
| Sep 30, 2024 | -114.07% |
| Jun 30, 2024 | -2.29% |
| Mar 31, 2024 | 49.87% |
| Dec 31, 2023 | 21.59% |
| Sep 30, 2023 | 38.28% |
| Jun 30, 2023 | 31.70% |
| Mar 31, 2023 | 26.89% |
| Dec 31, 2022 | 19.21% |
| Sep 30, 2022 | 18.18% |
| Jun 30, 2022 | 18.85% |
| Mar 31, 2022 | 25.50% |
| Dec 31, 2021 | 27.06% |
| Sep 30, 2021 | 27.04% |